Amgen

Amgen (amgn) Stock Moves -0.52%: What You Should Know

Amgen (AMGN) closed at $227.72 in the latest trading session, marking a -0.52% move from the prior day. This change was narrower than the S&P 500's 1.89% loss on the day. Elsewhere, the Dow lost 1.3%, while the tech-heavy Nasdaq lost 0.17%.Coming...
Related topics: Nasdaq, US Equity Markets

Read More →

Amgen's (amgn) Kras Inhibitor Gets Nod In Japan For Lung Cancer

Amgen Inc. AMGN announced that the Japan Ministry of Health, Labour and Welfare has approved its KRAS inhibitor, Lumakras (sotorasib). The drug is now approved in Japan for the treatment of KRAS G12C-mutated positive unresectable, advanced/recurrent...
Related topics: Lung Cancer, Cancer, Oncology

Read More →

Bridgebio (bbio), Amgen Partner In Advanced Solid Tumors Study

BridgeBio Pharma, Inc. BBIO announced that it has entered into a non-exclusive clinical collaboration agreement with Amgen AMGN to evaluate the combination of its investigational SHP2 inhibitor BBP-398 with the latter’s KRAS G12C inhibitor...
Related topics: Cancer, Medical Research

Read More →

Biotech Stock Roundup: Biib's Ad Drug Update, Amgn's Drug Approval & Other Updates

Quite a few regular pipeline and regulatory updates grabbed focus in the biotech sector this week. Importantly, updates on COVID-19 vaccines and treatments continue to be in the spotlight amid the rapidly spreading Omicron variant.Recap of the...

Read More →

Why The Earnings Surprise Streak Could Continue For Amgen (amgn)

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Amgen (AMGN), which belongs to the Zacks Medical - Biomedical and Genetics industry.This world's...

Read More →

Amgen (amgn) Inks Multi-target Deal To Make Protein Therapeutics

Amgen Inc. AMGN announced that it has entered into a research collaboration agreement with Massachusetts-based private biotech Generate Biomedicines to discover and develop protein therapeutics for five clinical targets in several therapeutic areas...
Related topics: Proteins, Medical Research

Read More →

Wednesday Afternoon Analyst Upgrades And Downgrades: Altria, Bp, Peloton, Pfizer And More

Wednesday afternoon's top analyst upgrades and downgrades included Adobe, Altria, Amgen, Beyond Meat, BP, Murphy Oil, Northrop Grumman, Occidental Petroleum, Peloton Interactive, Pfizer,...
Related topics: Altria Group (MO), Pfizer, Northrop Grumman

Read More →

What Does This Label Expansion Mean For Amgen's Shareholders?

Late last December, Amgen (NASDAQ: AMGN) announced that the U.S. Food and Drug Administration (FDA) had expanded Otezla's approval from moderate to severe plaque psoriasis to include mild to moderate cases. What prompted the FDA to expand Otezla's...
Related topics: Nasdaq, Food And Drug Administration, Psoriasis

Read More →

Amgen (amgn) Gains As Market Dips: What You Should Know

Amgen (AMGN) closed the most recent trading day at $227.84, moving +0.51% from the previous trading session. This change outpaced the S&P 500's 0.06% loss on the day. Elsewhere, the Dow gained 0.59%, while the tech-heavy Nasdaq lost 0.3%.Prior to...
Related topics: Nasdaq, US Equity Markets

Read More →

These 3 Stocks Just Hiked Their Dividends: Should You Buy Them?

For an income investor, there is no greater gift during the holiday season than a robust dividend raise. That's because more passive income can provide you with a floor in your standard of living and ease your financial worries.Pharma stocks Amgen...
Related topics: Dividend, Nasdaq, US Equity Markets

Read More →

Biotech Stock Roundup: Regulatory Updates From Biib, Amgn And Nvax & More

While updates on COVID-19 vaccines and treatments remain in the spotlight amid the rapidly spreading Omicron variant, the biotech sector was also in focus over the past week with drug approvals, label expansion of existing drugs and other regular...

Read More →

Amgen, Astrazeneca's Asthma Drug Tezepelumab Gets Fda Nod

Amgen AMGN along with its partner AstraZeneca AZN announced that the FDA has granted approval to their monoclonal antibody, tezepelumab, for the treatment of severe asthma. The medicine will be marketed by the trade name of Tezspire and can be...
Related topics: Astrazeneca, Asthma, Food And Drug Administration

Read More →

Can’t Make This Up: Vaccine Maker Moderna Pulls Out Of J.p. Morgan Healthcare Conference Due To...

You can’t make this up. Some of the most significant names in biotechnology, including Moderna and Amgen have pulled out of the upcoming J.P. Morgan Healthcare Conference in San Francisco due to COVID-19 concerns, according to an exclusive...
Related topics: Vaccines, Biotechnology

Read More →

Amgen (amgn) Gains As Market Dips: What You Should Know

Amgen (AMGN) closed at $213.74 in the latest trading session, marking a +1.11% move from the prior day. This move outpaced the S&P 500's daily loss of 0.75%. At the same time, the Dow lost 0.3%, and the tech-heavy Nasdaq lost 0.23%.Coming into...
Related topics: Nasdaq, US Equity Markets

Read More →

Thursday Afternoon’s Analyst Upgrades And Downgrades: Abbvie, Occidental Petroleum, Pfizer, Yum!...

Thursday afternoon's top analyst upgrades and downgrades included AbbVie, Allstate, Amgen, Occidental Petroleum, Pfizer, SunPower, Twilio and Yum! Brands.
Related topics: Pfizer, Allstate (ALL)

Read More →

Biotech Stock Roundup: Vrtx, Amgn's Pipeline Updates, Bpmc's Acquisition & More

The biotech sector has been in focus over the past week with acquisition news, label expansion of existing drugs and other regulatory updates.Recap of the Week’s Most Important Stories:Vertex Up on Study Results: Shares of Vertex...
Related topics: Vertex Pharmaceuticals

Read More →

Amgen (amgn) Kyprolis Gets Fda Nod For Use With Darzalex Faspro

Amgen Inc. AMGN announced that the FDA has granted approval to its multiple myeloma drug, Kyprolis, for use in combination with J&J’s JNJ Darzalex Faspro (daratumumab and hyaluronidase-fihj).Darzalex Faspro is the subcutaneous formulation...
Related topics: Food And Drug Administration

Read More →

Amgen (amgn) Down 7.9% Since Last Earnings Report: Can It Rebound?

It has been about a month since the last earnings report for Amgen (AMGN). Shares have lost about 7.9% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Amgen due...

Read More →

Top Analyst Reports For Disney, Amgen & Booking.com

Monday, November 15, 2021The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Company (DIS), Amgen Inc. (AMGN) and...
Related topics: Disney

Read More →

Amgen's (amgn) Kras Inhibitor Gets Chmp Nod For Lung Cancer

Amgen Inc. AMGN announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (“CHMP”) has rendered a positive opinion on, and has recommended conditional marketing authorization to its KRAS...
Related topics: Lung Cancer, Cancer, Oncology, Marketing

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.